First reported case of late recurrence of pulmonary mucormycosis in a renal transplant recipient with poorly controlled diabetes mellitus
Abstract Pulmonary mucormycosis (PM) is a rare, life‐threatening fungal infection usually affecting immunocompromised patients. Its incidence is rising, with a recent outbreak associated with COVID‐19 co‐infection. Amphotericin B along with early surgery are considered the standard treatment. Recurr...
Guardado en:
Autores principales: | Cheuk Cheung Derek Leung, Yu Hong Chan, Man Ying Ho, Ming Chiu Chan, Chun Hoi Chen, Chin Tong Kwok, Yiu Cheong Yeung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/22b1036d9b5540348bb5a5ece3e32856 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
por: F. Yuan, et al.
Publicado: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
por: Tonya N. Watkins, et al.
Publicado: (2018) -
Systemic mucormycosis caused by Rhizopus microsporus in a captive bottlenose dolphin
por: Lingling Chang, et al.
Publicado: (2021) -
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
por: Junyan Qu, et al.
Publicado: (2021) -
GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis
por: Abdullah Alqarihi, et al.
Publicado: (2020)